Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the ...
LOS ANGELES, Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB)—Enochian BioSciences (the Company) recently announced significant progress toward re-prioritizing its focus on curing some of the world’s ...
Enochian Biosciences is a pre-clinical stage biotech that purchased its HIV drug IP from Weird Science, LLC. ENOB's lead scientist and HIV IP inventor does not appear to have any biotech experience, ...
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enochian Biosciences Inc. (NASDAQ: ENOB) securities between January 17, 2018 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback